Integrative Approaches For Cancer Survivorship 2: Project 1 (IACS2)
Developing an Integrative Ayurvedic Intervention for Breast Cancer Survivorship
Studieöversikt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Detaljerad beskrivning
Studietyp
Studietyp
Inskrivning (Faktisk)
Inskrivning
Fas
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
California
-
San Francisco, California, Förenta staterna, 94115
- University of California, San Francisco, Osher Center for Integrative Medicine
-
-
Deltagandekriterier
Urvalskriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Female breast cancer survivor who is over 1 month and less than 24 months beyond the completion of primary therapy (surgery, radiation, and chemotherapy)
- Having received chemotherapy as part of their primary therapy for breast cancer
- Be in complete remission
- Aged 18 years or older
- Able to read, write, and understand English
- Karnofsky Performance Status (KPS) greater than or equal to 60
- Have impaired quality of life
- Ability to give informed consent
Exclusion Criteria:
- Having received Ayurvedic treatment within 6 months of study enrollment
- Receiving chemotherapy or radiotherapy at the time of study enrollment. Anti-her2 directed therapy is not exclusionary.
- Being within 1 month (before or after) of surgery for breast cancer (including breast reconstructive surgery). Smaller surgical procedures such as implant exchange are not exclusionary.
- Patients on adjuvant hormone therapy for less than 2 months
- Have surgery for breast cancer or breast reconstructive surgery planned during the initial 6 month study period. Smaller surgical procedures such as implant exchange are not exclusionary.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Stödjande vård
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Antal vapen
Vapen och interventioner
Deltagargrupp / ArmDeltagargrupp / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Experimentell: Integrative Medicine Intervention
Study participants will attend 14 visits with an integrative medicine clinician over the course of 6 months followed by a 6 month maintenance phase.
The treatment modalities employed in the study will include nutrition and lifestyle recommendations.
|
Vad mäter studien?
Primära resultatmått
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in quality of life over 12 months
Tidsram: Baseline, 3 months, 6 months, 12 months
|
The investigators will use the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ C30) in conjunction with a Breast Cancer-Specific Subscale (BR23) to collect data on qualify of life and cancer-related symptoms.
|
Baseline, 3 months, 6 months, 12 months
|
Sekundära resultatmått
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in fatigue over 12 months
Tidsram: Baseline, 3 months, 6 months, 12 months
|
The investigators will use the Lee Fatigue Scale (LFS) to collect data on fatigue.
|
Baseline, 3 months, 6 months, 12 months
|
|
Change in sleep quality over 12 months
Tidsram: Baseline, 3 months, 6 months, 12 months
|
The investigators will use the General Sleep Disturbance Scale (GSDS) to collect data on sleep disturbance.
|
Baseline, 3 months, 6 months, 12 months
|
|
Change in anxiety over 12 months
Tidsram: Baseline, 3 months, 6 months, 12 months
|
The investigators will use the Spielberger State Anxiety Inventory (STAI-S) to collect data on anxiety.
|
Baseline, 3 months, 6 months, 12 months
|
|
Change in depressive symptoms over 12 months
Tidsram: Baseline, 3 months, 6 months, 12 months
|
The investigators will use the Center for Epidemiological Studies - Depression Scale (CES-D) to collect data on depressive symptoms.
|
Baseline, 3 months, 6 months, 12 months
|
|
Change in pain over 12 months
Tidsram: Baseline, 3 months, 6 months, 12 months
|
The investigators will use the Brief Pain Inventory (BPI) to collect data on pain intensity and interference with function.
|
Baseline, 3 months, 6 months, 12 months
|
|
Change in diet over 12 months
Tidsram: Baseline, 3 months, 6 months, 12 months
|
The investigators will use the Automated Self-Administered 24-hour Recall (ASA24) to assess dietary recall over a 24 hour period.
|
Baseline, 3 months, 6 months, 12 months
|
Samarbetspartners och utredare
Sponsor
Sponsor
Samarbetspartners
Samarbetspartners
Utredare
Utredare
- Huvudutredare: Anand Dhruva, MD, University of California, San Francisco
Studieavstämningsdatum
Studera stora datum
Studiestart
Studiestart
Primärt slutförande (Faktisk)
Primärt slutförande
Avslutad studie (Faktisk)
Avslutad studie
Studieregistreringsdatum
Först inskickad
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Första postat
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste uppdatering publicerad
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
Andra studie-ID-nummer
- 16-18567
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .